First, it is the only international meeting that focuses entirely on the pharmacological therapy of Alzheimer Disease with particular emphasis on the discovery of new drugs. The theme includes: drug development at different preclinical and clinical stages, results of clinical trials and pharmaco-economics implications.

Second, the meeting is organized by an American (Southern Illinois University, School of Medicine in Springfield Illinois, USA) and two European (University of Geneva, Medical School Dept. of Rehabilitation and Geriatrics, and Karolinska Institutet, Dept. of Neurobiology, Care Sciences and Society, Stockholm) universities.